Catalyst Wire Dossier Catalyst Wire Dossier

ION283

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ION283, covering 2025-12-18 to 2025-12-18. Get the full timeline:

Most recent: Clinical Trial Update: A Safety and Efficacy of Intrathecally Administered ION283 in Patients With Lafora Disease [Phase 1, Phase 2]

See pricing